Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-CD8 beta [CD8b255R1]

Anti-CD8 beta [CD8b255R1]
Product Type: Therapeutics (In Vivo)
Format: Anti-CD8 beta, CD8B255.1, rhesusized variable region, rhesus IgG1 Fc
Clone ID: [CD8b255R1]
RRID: AB_2716321
Common Names: Anti-CD8 beta [CD8b255R1] | Depleting anti-CD8beta (rhesus recombinant) | PR-2557 | NHP01 | aCD8beta_255.1_rz_G1k_mamu
Target: CD8 beta
Reactivity: Rhesus Macaque (Macaca mulatta) Cynomolgus Monkey (Macaca fascicularis)
Applications: in vivo; depletion
Description:

CD8b255R1: Rhesus recombinant, CDR-grafted anti-CD8beta IgG1-kappa antibody.

Publication describing T cell depletion profile in cynomolgus monkeys: PMID: 31092584
Modifications: None
Restrictions: No
Sponsor: ORIP
How to cite (Methods): "The rhesus IgG1 recombinant Anti-CD8 beta [CD8b255R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-2557, RRID:AB_2716321)."
How to cite (Acknowledgments): "The Anti-CD8 beta [CD8b255R1] antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116)".

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2022